[Drugs and other substances inducing hypertension].
Ohno
A
A
Department of Medicine, Kidney Center, Tokyo Women's Medical College.
Tanaka
M
M
Sugino
N
N
D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D016572:Cyclosporine / Q000009:adverse effects*; D003613:Danazol / Q000009:adverse effects; D004921:Erythropoietin / Q000009:adverse effects*; D005110:Extracellular Space / Q000378:metabolism*; D006034:Glycyrrhetinic Acid / Q000009:adverse effects / Q000031:analogs & derivatives; D019695:Glycyrrhizic Acid; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D011994:Recombinant Proteins / Q000009:adverse effects; D012982:Sodium, Dietary / Q000009:adverse effects*
D000929:Antidepressive Agents, Tricyclic; D003276:Contraceptives, Oral; D008996:Monoamine Oxidase Inhibitors; D011994:Recombinant Proteins; D012982:Sodium, Dietary; D004921:Erythropoietin; D019695:Glycyrrhizic Acid; D016572:Cyclosporine; D003613:Danazol; D006034:Glycyrrhetinic Acid